Medicine and Dentistry
Patient
100%
Child
41%
Atopic Dermatitis
36%
Diseases
21%
Immune Deficiency
20%
T Cell
17%
Infection
17%
Skin
15%
Age
15%
Therapeutic Procedure
13%
Gene
13%
Syndrome
12%
Inpatient
12%
Cells
11%
Cytokinesis
11%
Autoimmune Lymphoproliferative Syndrome
11%
Eczema
11%
Cytotoxic T-Cell
11%
B Cell
10%
Phenotype
10%
Lymphocyte
10%
Family
10%
Diagnosis
9%
Infant
9%
In Vitro
9%
Inflammatory Bowel Disease
9%
Dupilumab
9%
Allergy
9%
Cytokine
8%
Prevalence
8%
Genotype
8%
Food Allergy
7%
Association
7%
Hematopoietic Stem Cell Transplantation
7%
Immunoglobulin E
7%
Differentiation
7%
Complement Component C1q
6%
Childhood
6%
Parent
6%
Receptor
6%
Programmed Cell Death
6%
Mast Cell
6%
X-Linked Lymphoproliferative Disease
5%
Anaphylaxis
5%
Tryptase
5%
Adult
5%
Mucocutaneous Candidiasis
5%
Virus Infection
5%
Survival
5%
Clinical Feature
5%
Immunology and Microbiology
Mutation
40%
Atopic Dermatitis
40%
Immunodeficiency
32%
STAT3
23%
B Cell
18%
Age
18%
Dupilumab
16%
Skin
16%
Phenotype
15%
Cells
15%
Eczema
13%
Mast Cell
12%
Gene
11%
Monospecific Antibody
11%
Chronic Mucocutaneous Candidiasis
10%
Common Variable Immunodeficiency
10%
Life
10%
STAT1
10%
Human
10%
Hematopoietic Stem Cell Transplantation
10%
Complement Component C1q
9%
Immunity
9%
Genotype
9%
Prevalence
8%
Mouse
8%
Intravenous Immunoglobulin
8%
Staphylococcus Aureus
8%
Neutrophil Granulocyte
7%
Serotype
7%
Reduction (Chemistry)
7%
Immunoglobulin M
7%
Autoimmune Polyendocrine Syndrome Type 1
7%
Differentiation
7%
T-Helper Cell
7%
Lymphocytes
7%
Signal Transduction
7%
Immunodeficiency
6%
Follicular B Helper T Cells
6%
CTLA-4
6%
Anaphylaxis
6%
Keratinocyte
6%
Staphylococcus aureus
6%
Autoimmune Regulator
6%
Immunoglobulin E
6%
Auto-immunity
6%
Autoantibodies
6%
Interleukin 21
6%
Contrast
6%
Dose
5%
Candida
5%
